Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Autoimmune Diseases
Biotech
Zenas, Bicara set out to raise $180M-plus in separate IPOs
After revealing intentions to hit the public markets less than a month ago, Zenas and Bicara on Friday offered details behind their planned IPOs.
James Waldron
,
Eric Sagonowsky
Sep 6, 2024 8:18am
Navigator raises $100M to develop new autoimmune pipeline
Aug 27, 2024 8:50am
Cue lays off 25%, prioritizing preclinical autoimmune assets
Jul 26, 2024 4:29am
J&J's phase 2 Sjögren's data support FcRn strategy
Jun 17, 2024 8:47am
Cullinan rebrands, halts lymphoma trial in autoimmune refocus
Apr 16, 2024 10:05am
Double autoimmune acquisitions as Century, Eliem pick up peers
Apr 11, 2024 9:06am